New glioblastoma vaccine shows promising results in phase Ib clinical trial

A new vaccine for glioblastoma brain cancer suspends tumor growth and is well tolerated by patients, according to the results of an early phase clinical trial.

from Neuroscience News Updates https://ift.tt/2I1NIop